News
Sarepta stock (SRPT) declined 5% in premarket trade, after falling 36% on Friday, when it disclosed a patient death due to liver failure.
Shares of life sciences company Revvity (NYSE:RVTY) fell 7.6% in the afternoon session after the company lowered its ...
StockStory.org on MSN2h
Why QuidelOrtho (QDEL) Shares Are Sliding TodayShares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 3.7% in the morning session after the company ...
S&P 500 posts first close above 6,300, Nasdaq hits a record ahead of big tech earnings: Live updates
U.S. stocks moved higher on Monday as optimism around earnings overshadowed any investor fears over the latest developments ...
Though there were no historical benchmarks to gauge the response, the Dollar Index could fall more than 5%. Sterling edged higher versus the euro but remained weaker against a firmer dollar after the ...
7d
Zacks Investment Research on MSNSRPT Down After Third Death in Muscular Dystrophy Gene Therapy ProgramShares of Sarepta Therapeutics SRPT nosedived 35.9% on Friday following the death of a patient dosed with one of its ...
Sarepta Therapeutics (SRPT) shares dropped sharply on Monday following news that the FDA is investigating a patient death potentially connected to its gene therapy, Elevidys.
7don MSN
Sarepta Therapeutics' (SRPT) stock continued to sink Tuesday, down more than 4% in pre-market trade, following a rough end to ...
IT Quantitative Stock Analysis July 01, 2025 — 04:03 pm EDT Written by John Reese for Validea -> Below is Validea's guru fundamental report for GARTNER INC (IT).
After rolling through March and April, Lucid stock encountered resistance again in May. Early in the month, the company reported Q1 2025 financial results that jump-started a sell-off in Lucid stock.
QUBT Quantitative Stock Analysis June 28, 2025 — 03:06 pm EDT Written by John Reese for Validea -> Below is Validea's guru fundamental report for QUANTUM COMPUTING INC (QUBT).
The Mass. 100 index of largest publicly traded companies in Massachusetts gets a refresh. See which firms rose, fell and debuted on the list for 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results